TissueTinker

Propulsé - BioTech | Hiver 2025

About the company

TissueTinker’s 3D bioprinted tumor models replicate critical aspects of cancer growth and metastasis to better mirror human tumors. Our proprietary solid tumor model library aims to accelerate therapeutic development with validated, accessible preclinical technology.

The founders

Benjamin Ringler
CEO/Co-founder
Isabelle Dummer
Co-founder
Madison Santos
Co-founder
CleanTech

CataLum Technologies

Hiver 2025

Technologies Volinergy Inc.

Été 2022

CONNEKTICA

Été 2020